2-Bromo-1,3-dimethyl-5-(1-methylethoxy)benzene, 95+%, 1g

(Z)-tert-Butyl 2,3,6,7-tetrahydroazepine-1-carboxylate, 95.0%, 5g

1-Quinolin-5-yl-methylamine hydrochloride, 95.0%, 250mg

(S)-2-((((9H-Fluoren-9-yl)methoxy)carbonyl)(methyl)amino)-3-(3-chlorophenyl)propanoic acid, 98%, 5g

1-(dimethylamino)-4-piperidinone, 95.0%, 10g

tert-Butyl 2-ethyl-4-oxopiperidine-1-carboxylate, 97.0%, 5g

((4-Iodophenyl)ethynyl)trimethylsilane, 95.0%, 25g

6-oxa-3-thiabicyclo[3.1.0]hexane 3,3-dioxide, 95.0%, 250mg

2-(3-Bromophenyl)-2-oxoacetic acid, 95.0%, 250mg

2,3-Dihydro-pyrrolo[3,2-c]pyridine-1-carboxylic acid tert-butyl ester, 98+%, 100mg

5-(4-pyridinyl)-N-[2-[4-(2-pyridinylmethyl)-1-piperazinyl]-5-(trifluoromethyl)phenyl]-2-furancarboxamide, 25mg

ICP multi-element standard solution CR-10, ROTI®Star, 250 ml, HDPE

Dansyl-L-valine>98.0%(T)(HPLC)100mg